Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/39350
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | CUPPENS, Kristof | - |
dc.contributor.author | Baas, Paul | - |
dc.date.accessioned | 2023-01-30T08:54:15Z | - |
dc.date.available | 2023-01-30T08:54:15Z | - |
dc.date.issued | 2023 | - |
dc.date.submitted | 2023-01-26T15:42:37Z | - |
dc.identifier.citation | Translational Lung Cancer Research, 12 (1) , p. 11 -13 | - |
dc.identifier.uri | http://hdl.handle.net/1942/39350 | - |
dc.language.iso | en | - |
dc.publisher | AME PUBLISHING COMPANY | - |
dc.rights | Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the noncommercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/. | - |
dc.subject.other | Early-stage lung cancer | - |
dc.subject.other | perioperative strategy | - |
dc.subject.other | perioperative immune checkpoint inhibition | - |
dc.subject.other | perioperative targeted therapy | - |
dc.title | The path forward in early-stage lung cancer | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 13 | - |
dc.identifier.issue | 1 | - |
dc.identifier.spage | 11 | - |
dc.identifier.volume | 12 | - |
local.format.pages | 3 | - |
local.bibliographicCitation.jcat | A2 | - |
dc.description.notes | Baas, P (corresponding author), Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands.; Baas, P (corresponding author), Leiden Univ, Dept Pulmonol, Med Ctr, Leiden, Netherlands. | - |
dc.description.notes | p.baas@nki.nl | - |
local.publisher.place | FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG 00000, PEOPLES R CHINA | - |
local.type.refereed | Refereed | - |
local.type.specified | Editorial Material | - |
dc.identifier.doi | 10.21037/tlcr-22-546 | - |
dc.identifier.isi | 000907560600001 | - |
local.provider.type | wosris | - |
local.description.affiliation | [Cuppens, Kristof] Jessa Hosp, Dept Pulmonol & Thorac Oncol, Hasselt, Belgium. | - |
local.description.affiliation | [Cuppens, Kristof] Hasselt Univ, Fac Med & Life Sci LCRC, Diepenbeek, Belgium. | - |
local.description.affiliation | [Cuppens, Kristof; Baas, Paul] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands. | - |
local.description.affiliation | [Baas, Paul] Leiden Univ, Dept Pulmonol, Med Ctr, Leiden, Netherlands. | - |
local.uhasselt.international | yes | - |
item.fullcitation | CUPPENS, Kristof & Baas, Paul (2023) The path forward in early-stage lung cancer. In: Translational Lung Cancer Research, 12 (1) , p. 11 -13. | - |
item.accessRights | Open Access | - |
item.fulltext | With Fulltext | - |
item.contributor | CUPPENS, Kristof | - |
item.contributor | Baas, Paul | - |
crisitem.journal.issn | 2218-6751 | - |
crisitem.journal.eissn | 2226-4477 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
The path forward in early-stage lung cancer.pdf | Published version | 106.77 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.